The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia

Condition:   Barrett's Oesophagus Interventions:   Diagnostic Test: Cytosponge test;   Diagnostic Test: Assessment of the panel of molecular biomarkers: IM-SCORE, TFF3 protein expression, methylation panel, p53 mutation;   Diagnostic Test: Oesophagogastroduodenoscopy Sponsors:   University of Cambridge;   University of Nottingham Not yet recruiting

Source: ClinicalTrials.gov - November 7, 2019 Category: Research Source Type: clinical trials